- Home
- HURA vs ABTC Comparison
HURA vs ABTC Comparison
Compare HURA & ABTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURA
- ABTC
- Stock Information
- Founded
- HURA 2009
- ABTC 2024
- Country
- HURA United States
- ABTC United States
- Employees
- HURA N/A
- ABTC N/A
- Industry
- HURA
- ABTC EDP Services
- Sector
- HURA
- ABTC Technology
- Exchange
- HURA Nasdaq
- ABTC Nasdaq
- Market Cap
- HURA 145.6M
- ABTC 122.5M
- IPO Year
- HURA N/A
- ABTC N/A
- Fundamental
- Price
- HURA $2.34
- ABTC N/A
- Analyst Decision
- HURA Strong Buy
- ABTC
- Analyst Count
- HURA 2
- ABTC 0
- Target Price
- HURA $11.50
- ABTC N/A
- AVG Volume (30 Days)
- HURA 823.7K
- ABTC 15.8M
- Earning Date
- HURA 08-14-2025
- ABTC 11-08-2025
- Dividend Yield
- HURA N/A
- ABTC N/A
- EPS Growth
- HURA N/A
- ABTC N/A
- EPS
- HURA N/A
- ABTC N/A
- Revenue
- HURA N/A
- ABTC N/A
- Revenue This Year
- HURA N/A
- ABTC N/A
- Revenue Next Year
- HURA N/A
- ABTC N/A
- P/E Ratio
- HURA N/A
- ABTC N/A
- Revenue Growth
- HURA N/A
- ABTC N/A
- 52 Week Low
- HURA $1.80
- ABTC $6.24
- 52 Week High
- HURA $8.40
- ABTC $14.52
- Technical
- Relative Strength Index (RSI)
- HURA 38.05
- ABTC N/A
- Support Level
- HURA $2.43
- ABTC N/A
- Resistance Level
- HURA $2.65
- ABTC N/A
- Average True Range (ATR)
- HURA 0.18
- ABTC 0.00
- MACD
- HURA -0.07
- ABTC 0.00
- Stochastic Oscillator
- HURA 5.39
- ABTC 0.00
About HURA TuHURA Biosciences Inc. Common Stock
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.